NASDAQ:AKRO

Akero Therapeutics, Inc.

Stock

USD

Last Close

28.32

26/07 20:00

Market Cap

1.66B

Beta: −0.94

Volume Today

412.32K

Avg: 611.93K

PE Ratio

−9.80

PFCF: −9.21

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-81.71M -	-43.76M 46.45%	-79.21M 81.02%	-100.78M 27.23%	-112.03M 11.17%	-151.76M 35.46%
depreciation and amortization		-104K -	17K 116.35%	41K 141.18%	43K 4.88%	29K 32.56%
deferred income tax		104K -	83K 20.19%	1.07M 1,190.36%		645K -
stock based compensation	121K -	1.77M 1,362.81%	6.02M 240.23%	10.05M 66.95%	23.24M 131.18%	21.50M 7.51%
change in working capital	1.06M -	6.46M 509.05%	2.08M 67.73%	9.73M 366.52%	-4.46M 145.84%	-6.67M 49.59%
accounts receivables
inventory
accounts payables	1.31M -	-426K 132.44%	2.48M 682.39%	3.27M 31.92%	968K 70.42%	-645K 166.63%
other working capital	-252K -	6.89M 2,833.33%	-396K 105.75%	6.45M 1,729.80%	-5.43M 184.09%	-6.03M 11.02%
other non cash items	75.91M -	-104K 100.14%	196K 288.46%	203K 3.57%	689K 239.41%	-9.11M 1,422.06%
net cash provided by operating activities	-4.63M -	-35.63M 670.31%	-70.80M 98.74%	-79.68M 12.54%	-92.52M 16.11%	-145.37M 57.12%
investments in property plant and equipment	-5M -		-148K -
acquisitions net			9.61K -
purchases of investments		-71.51M -	-115.04M 60.86%	-43.56M 62.13%	-101.45M 132.88%	-433.12M 326.95%
sales maturities of investments			105.42M -	85.84M 18.58%	37.62M 56.17%	209.50M 456.87%
other investing activites			-9.61K -
net cash used for investing activites	-5M -	-71.51M 1,330.26%	-9.76M 86.35%	42.28M 533.15%	-63.83M 250.96%	-223.62M 250.37%
debt repayment					-395K -	-15M 3,697.47%
common stock issued		95.45M -	202.55M 112.21%	602K 99.70%	241.20M 39,966.45%	338.32M 40.26%
common stock repurchased		85K -	198K 132.94%	373K 88.38%	280K 24.93%	396K 41.43%
dividends paid						-229.10M -
other financing activites	85.01M -	451K 99.47%	355K 21.29%	-373K 205.07%	14.55M 4,000%	258.71M 1,678.43%
net cash used provided by financing activities	85.01M -	95.99M 12.92%	203.11M 111.60%	602K 99.70%	255.63M 42,363.79%	353.32M 38.21%
effect of forex changes on cash						108K -
net change in cash	75.38M -	-11.15M 114.79%	122.54M 1,198.83%	-36.80M 130.03%	99.29M 369.82%	-15.57M 115.68%
cash at beginning of period	618K -	76M 12,197.73%	64.85M 14.67%	187.39M 188.97%	150.59M 19.64%	249.77M 65.86%
cash at end of period	76M -	64.85M 14.67%	187.39M 188.97%	150.59M 19.64%	249.88M 65.93%	234.21M 6.27%
operating cash flow	-4.63M -	-35.63M 670.31%	-70.80M 98.74%	-79.68M 12.54%	-92.52M 16.11%	-145.37M 57.12%
capital expenditure	-5M -		-148K -
free cash flow	-9.63M -	-35.63M 270.15%	-70.95M 99.15%	-79.68M 12.30%	-92.52M 16.11%	-145.37M 57.12%

All numbers in USD (except ratios and percentages)